Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma
about
Linker stability influences the anti-tumor activity of acetazolamide-drug conjugates for the therapy of renal cell carcinoma.Multivalency Increases the Binding Strength of RGD Peptidomimetic-Paclitaxel Conjugates to Integrin αV β3.Antibody drug conjugates and bystander killing: is antigen-dependent internalisation required?Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A Comparative Analysis.Targeted Delivery of Cytotoxic Drugs: Challenges, Opportunities and New Developments.Enhanced Therapeutic Activity of Non-Internalizing Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX in Combination With Targeted Interleukin-2.
P2860
Acetazolamide Serves as Selective Delivery Vehicle for Dipeptide-Linked Drugs to Renal Cell Carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Acetazolamide Serves as Select ...... Drugs to Renal Cell Carcinoma
@en
Acetazolamide Serves as Select ...... Drugs to Renal Cell Carcinoma.
@nl
type
label
Acetazolamide Serves as Select ...... Drugs to Renal Cell Carcinoma
@en
Acetazolamide Serves as Select ...... Drugs to Renal Cell Carcinoma.
@nl
prefLabel
Acetazolamide Serves as Select ...... Drugs to Renal Cell Carcinoma
@en
Acetazolamide Serves as Select ...... Drugs to Renal Cell Carcinoma.
@nl
P2860
P1476
Acetazolamide Serves as Select ...... Drugs to Renal Cell Carcinoma
@en
P2093
Samuele Cazzamalli
P2860
P304
P356
10.1158/1535-7163.MCT-16-0283
P577
2016-09-08T00:00:00Z